International Stroke Conference 2025  /  Neuroendovascular Posters II  /  Acute Ischemic Stroke Patient Factors Associated with Poor Outcomes in Patients with Favorable Collaterals and Successful Thrombectomy
Logo

American Heart Association

  12
  0

Final ID: TP259

Acute Ischemic Stroke Patient Factors Associated with Poor Outcomes in Patients with Favorable Collaterals and Successful Thrombectomy

Abstract Body: Background
Endovascular treatment (EVT) is an effective treatment for acute ischemic stroke in anterior large vessel occlusions. Despite successful reperfusion, many patients still have unfavorable outcomes even in the presence of favorable arterial collaterals. We determined patient characteristics, treatment details and imaging characteristics associated with favorable outcome in patients with good collaterals who had successful EVT.

Methods
In a post hoc analysis of the prospective CRISP 2 study, we identified patients with successful reperfusion following EVT (TICI 2b-3) and good collaterals (Tan ≥2). These patients were dichotomized into favorable (mRS 0-2) and unfavorable outcome (mRS 3-6) groups. Multivariate analyses were performed to identify clinical, imaging, and treatment predictors of favorable outcome.

Results
92 patients were included, and 31 patients (33.7%) had favorable outcomes. There were no differences in the number of females (16 patients [52%] versus 33 patients [54%]; p=0.821) or age (71 years, [IQR 56-79] versus 68 years [IQR 57-79]; p=0.859) in favorable versus unfavorable groups, respectively. Favorable outcome patients had lower pre-treatment mRS (p<0.001), more frequent administration of intravenous thrombolysis (52% versus 23%; p=0.006), shorter EVT procedure times (27 min (IQR 23-40) versus 46 min (IQR 27-64), and lower NIHSS before EVT (12 [IQR 9-15] versus 16 [IQR 12-20]; p=0.006). There were no differences in the frequency of TICI 3 rates (48% vs. 38%; p=0.325) or first pass effect between the two groups (61% vs. 57%; p=0.719). In a multivariable regression analysis, intravenous thrombolysis administration (OR 3.27 [95% CI: 1.04-10.33]; p = 0.043) and EVT procedure time (OR for every 5 min 0.98 [95% CI: 0.81-0.98]; p = 0.022) were modifiable predictors of favorable outcomes. Lower pre-stroke mRS also predicted favorable outcomes (p = 0.03).

Conclusions
Among patients with good collaterals and successful reperfusion following EVT, favorable outcomes were associated with lower baseline mRS, intravenous thrombolysis administration, and shorter EVT procedure times.
  • Kesten, Jamie  ( Stanford University , Palo Alto , California , United States )
  • Mlynash, Michael  ( Stanford University Medical Center , Palo Alto , California , United States )
  • Yuen, Nicole  ( Stanford University , Mountain View , California , United States )
  • Seners, Pierre  ( Stanford University , Palo Alto , California , United States )
  • Wouters, Anke  ( Stanford Stroke Center , Palo Alto , California , United States )
  • Schwartz, Maya  ( Stanford University , Palo Alto , California , United States )
  • Lansberg, Maarten  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Albers, Gregory  ( Stanford University Medical Center , Stanford , California , United States )
  • Heit, Jeremy  ( Stanford University , Palo Alto , California , United States )
    • Author Disclosures:
    Jamie Kesten: No Answer | Michael Mlynash: DO NOT have relevant financial relationships | Nicole Yuen: DO NOT have relevant financial relationships | Pierre Seners: DO have relevant financial relationships ; Speaker:ACTICOR Biotech:Past (completed) ; Speaker:Boerhinger Ingelheim:Expected (by end of conference) | Anke Wouters: DO NOT have relevant financial relationships | Maya Schwartz: DO NOT have relevant financial relationships | Maarten Lansberg: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Up To Date (Author):Active (exists now) ; Consultant:Biogen:Past (completed) ; Consultant:Roche:Past (completed) | Gregory Albers: DO have relevant financial relationships ; Consultant:iSchemaView:Active (exists now) ; Individual Stocks/Stock Options:iSchemaView:Active (exists now) ; Consultant:Genentech:Past (completed) | Jeremy Heit: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Ownership Interest:Dragon Medical:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Balt:Active (exists now) ; Consultant:MicroVention:Active (exists now)
Meeting Info:

International Stroke Conference 2025

2025

Los Angeles, CA

Session Info:

Neuroendovascular Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Automated Vessel Landmark Detection and AIF/VOF Validation for Enhanced CTP Analysis in Acute Ischemic Stroke

Lee Eunwoo, Lee Kijeong, Kim Gi-youn, Yang Hyeonsik, Hwang Jundong, Kim Donghyeon, Jung Woo Sang, Choi Jin Wook

A Multi-centre, Randomized, Controlled Study of External CounterPulsation for Patients with Recent Atherosclerotic Stroke (SPA)

Xiong Li, Chen Xiangyan, Leung Howan, Zhu Lixia, Leung Thomas, Wong Lawrence

More abstracts from these authors:
Comparing hypodensity and volume measurements for ischemic stroke patients in admission CT between CTP ischemic core, DWI, and deep learning based CT regions of interest

Van Voorst Henk, Mlynash Michael, Zaharchuk Greg, Lansberg Maarten, Albers Gregory, Heit Jeremy, Zamarud Aroosa, Liu Yongkai, Wouters Anke, Seners Pierre, Mahammedi Abdelkader, Verhaaren Benjamin, Christensen Soren, Yuen Nicole

Poor Comprehensive Cerebral Collateral Cascade is Associated with More and Faster Ischemic Core Growth During Inter-Hospital Transfer in Acute Ischemic Stroke Patients with a Large Vessel Occlusion

Zamarud Aroosa, Albers Gregory, Lansberg Maarten, Heit Jeremy, Seners Pierre, Yuen Nicole, Mlynash Michael, Wouters Anke, Van Voorst Henk, Kesten Jamie, Lugo Leonel, Faizy Tobias

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.

   Rate this abstract  (Maximum characters: 500)